However, inhibitory factors affect anti-tumor DC activity, including (but not limited to) tumor growth factor (TGF)-β (51), IL-10 (52), cytotoxic T-lymphocyte antigen (CTLA)-4 (53) and programmed cell death protein (PD)-1 expressions (51, 53), thus leading to cancer progression. This evidence concerns the gene IL10 and cancer.